PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21498735-3	2011	In preclinical models, exposure of pancreatic cancer cell lines to an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor plus gemcitabine suggested enhanced cytotoxicity of gemcitabine and induced apoptosis in tumor cells.	gemcitabine	188-199	epidermal growth factor receptor	Homo sapiens	70-102	
21498735-3	2011	In preclinical models, exposure of pancreatic cancer cell lines to an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor plus gemcitabine suggested enhanced cytotoxicity of gemcitabine and induced apoptosis in tumor cells.	gemcitabine	188-199	epidermal growth factor receptor	Homo sapiens	104-108	
21498735-4	2011	Erlotinib inhibited gemcitabine-induced phosphorylation of EGFR, which may promote cytotoxicity from gemcitabine.	gemcitabine	20-31	epidermal growth factor receptor	Homo sapiens	59-63	
21498735-4	2011	Erlotinib inhibited gemcitabine-induced phosphorylation of EGFR, which may promote cytotoxicity from gemcitabine.	gemcitabine	101-112	epidermal growth factor receptor	Homo sapiens	59-63